Skip to main content
Log in

Highlights from Transcatheter Cardiovascular Therapeutics 2009

  • Congress Report
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

This summary article provides an update on novel clinical trials in the field of cardiovascular (CV) medicine which were presented at the Transcatheter Cardiovascular Therapeutics meeting, held in San Francisco in September 2009. The data were presented by leading experts in the field with relevant positions in the trials and registries. Unpublished reports should be considered as preliminary data as the analysis may change in the final publications. This article provides the reader with comprehensive summaries of the most recent diagnostic and therapeutic developments in CV medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Maier LS, Baumhäkel M, Bohm M (2009) Hotline sessions presented at the American College of Cardiology Congress 2009. Clin Res Cardiol 98(6):345–352

    Article  PubMed  Google Scholar 

  2. Müller P, Rosenkranz S, Adam O, Custodis F, Böhm M (2008) Clinical trial updates and hotline sessions presented at the European Society of Cardiology Congress 2008. Clin Res Cardiol 97(12):851–864

    Article  PubMed  Google Scholar 

  3. Möllmann H, Nef H, Böhm M, Laufs U (2009) Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association. Clin Res Cardiol 98(1):1–7

    Article  PubMed  Google Scholar 

  4. Windecker S, Remondino A, Eberli FR et al (2005) Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353(7):653–662

    Article  CAS  PubMed  Google Scholar 

  5. Windecker S, Serruys PW, Wandel S et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372(9644):1163–1173

    Article  CAS  PubMed  Google Scholar 

  6. Tonino PA, De Bruyne B, Pijls NH et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224

    Article  CAS  PubMed  Google Scholar 

  7. Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057

    Article  CAS  PubMed  Google Scholar 

  8. Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281

    Article  PubMed  Google Scholar 

  9. Stone GW, Lansky AJ, Pocock SJ et al (2009) Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 360(19):1946–1959

    Article  CAS  PubMed  Google Scholar 

  10. Mehran R, Lansky AJ, Witzenbichler B et al (2009) Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 374(9696):1149–1159

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helge Möllmann.

Additional information

H. Möllmann and H. M. Nef contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möllmann, H., Nef, H.M., Hamm, C.W. et al. Highlights from Transcatheter Cardiovascular Therapeutics 2009. Clin Res Cardiol 98, 811–817 (2009). https://doi.org/10.1007/s00392-009-0090-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-009-0090-5

Keywords

Navigation